Wed, October 7, 2015
Tue, October 6, 2015
Mon, October 5, 2015
Fri, October 2, 2015
Thu, October 1, 2015
Wed, September 30, 2015
Tue, September 29, 2015
Mon, September 28, 2015
Fri, September 25, 2015

Matthew Harrison Upgraded (VRTX) to Buy and Increased Target to $148 on, Oct 2nd, 2015

Matthew Harrison of Morgan Stanley, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Buy and Increased Target from $118 to $148 on, Oct 2nd, 2015.

Matthew has made no other calls on VRTX in the last 4 months.



There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Biren Amin of "Jefferies" Initiated at Hold and Held Target at $130 on, Wednesday, September 9th, 2015
  • Ying Huang of "B of A Securities" Maintained at Hold with Increased Target to $133 on, Monday, July 6th, 2015


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Jasper Hellweg of "Argus Research" Upgraded from Hold to Strong Buy on, Monday, September 28th, 2015
  • Liisa Bayko of "JMP Securities" Maintained at Buy with Increased Target to $148 on, Thursday, July 30th, 2015